CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Network Study Title CIRB
AMC-107 AMC A Phase 2 Trial of Ixazomib for Kaposi Sarcoma Adult CIRB - Late Phase Emphasis
AMC-108 AMC Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma Adult CIRB - Late Phase Emphasis
AMC-110 AMC Risk-Adapted Therapy for HIV-Associated Anal Cancer Adult CIRB - Early Phase Emphasis
AMC-111 AMC Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living with HIV: A Feasibility Study Adult CIRB - Late Phase Emphasis
AMC-112 AMC Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma Adult CIRB - Late Phase Emphasis
AMC-115 AMC Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AIDS Malignancy Consortium Adult CIRB - Late Phase Emphasis
AMC-S005 AMC Biospecimen Collection and Donation to the AIDS and Cancer Specimen Resource (ACSR): A Companion Protocol to AMC Trials Adult CIRB - Late Phase Emphasis
ANBL00B1 COG Neuroblastoma Biology Studies Pediatric CIRB
ANBL00P3 COG A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients with Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated with Chemotherapy and Prednisone Pediatric CIRB
ANBL0322 COG A Phase II Study of hu14.18-IL2*(BB-IND-9798) In Children with Recurrent or Refractory Neuroblastoma Pediatric CIRB